Beneficial effect of the GLP-1 analogue liraglutide on blood pressure and cardiovascular biomarkers in subjects with Type 2 diabetes

被引：0
|
作者：
Vilsboell, T.
Zdravkovic, M.
Le-Thi, T.
Krarup, T.
Schmitz, O.
Courreges, J.
Verhoeven, R.
Buganova, I.
Madsbad, S.
机构：
[1] Gentofte Univ Hosp, Dept Internal Med, Copenhagen, Denmark
[2] Novo Nordisk AS, Clin Res Liraglutide, DK-2880 Bagsvaerd, Denmark
[3] Aarhus Univ, Dept Internal Med, Aarhus, Denmark
[4] Ctr Hosp Narbonne, Med Serv, Narbonne, France
[5] Poli Interne Geneeskunde, Gelre Ziekenhuizen, Apeldoorn, Netherlands
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Effect of the Combination Therapy of Liraglutide, a GLP-1 Receptor Analog, and IDegAsp in Patients with Type 2 Diabetes
    Harada, Marina
    Shinoda, Minori
    Sakamoto, Rika
    Suzuki, Jun
    Takahashi, Kenichiro
    Yamakawa, Tadashi
    DIABETES, 2018, 67
  • [22] The GLP-1 analogue liraglutide decreases the pro-inflammatory status of the heart in diabetes
    Emmens, R. W.
    Baylan, U.
    Naaijkens, B.
    Schalkwijk, C. G.
    Niessen, H. W. M.
    Krijnen, P. A. J.
    Simsek, S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 329 - 330
  • [23] The GLP-1 analogue, LY307161, potently lowers post prandial blood glucose in subjects with type 2 diabetes.
    Pascoe, S
    Payne, C
    Trautmann, M
    DIABETOLOGIA, 2000, 43 : A31 - A31
  • [24] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
    Ryan, Gina J.
    Hardy, Yolanda
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
  • [25] Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
    Lin, Chia-Hung
    Lee, Yun-Shien
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Chen, Zih-Syuan
    Tsai, Chi-Neu
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [26] Victoza - Liraglutide - Novo Nordisk - A GLP-1 analog for the treatment of type 2 diabetes
    不详
    FORMULARY, 2010, 45 (03) : 76 - 76
  • [27] GLP-1 for type 2 diabetes
    Ahren, Bo
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1239 - 1245
  • [28] Pharmacokinetics of the long-acting human GLP-1 analogue liraglutide in subjects with renal impairment
    Jacobsen, L. V.
    Hindsberger, C.
    Robson, R.
    Zdravkovic, M.
    DIABETOLOGIA, 2007, 50 : S352 - S352
  • [29] Liraglutide, a Once-Daily Human GLP-1 Analog, Reduces Systolic Blood Pressure with Minimal Impact from Weight Loss in Subjects with Type 2 Diabetes.
    Henry, R. R.
    Fonseca, V.
    Tabanera y Palacios, R.
    Brett, J.
    Plutzky, J.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [30] Pharmacokinetics of the long-acting human GLP-1 analogue liraglutide in subjects with renal impairment
    Jacobsen, Lisbeth V.
    Hindsberger, Charlotte
    Robson, Richard
    Zdravkovic, Milan
    DIABETES, 2007, 56 : A137 - A137
12345